Highly selective inhibition of histone demethylases by de novo macrocyclic peptides
JmjC histone demethylases (KDMs) are cancer targets due to their links to cell proliferation, but selective inhibition remains a challenge. Here the authors identify potent inhibitors of KDM4A-C—viain vitroselection from a vast library of cyclic peptides—that show selectivity over other KDMs.
Guardado en:
Autores principales: | Akane Kawamura, Martin Münzel, Tatsuya Kojima, Clarence Yapp, Bhaskar Bhushan, Yuki Goto, Anthony Tumber, Takayuki Katoh, Oliver N. F. King, Toby Passioura, Louise J. Walport, Stephanie B. Hatch, Sarah Madden, Susanne Müller, Paul E. Brennan, Rasheduzzaman Chowdhury, Richard J. Hopkinson, Hiroaki Suga, Christopher J. Schofield |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ef8ec2f09725496691198a2fa7af4d88 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Arginine demethylation is catalysed by a subset of JmjC histone lysine demethylases
por: Louise J. Walport, et al.
Publicado: (2016) -
Use of cyclic peptides to induce crystallization: case study with prolyl hydroxylase domain 2
por: Rasheduzzaman Chowdhury, et al.
Publicado: (2020) -
Macrocycle peptides delineate locked-open inhibition mechanism for microorganism phosphoglycerate mutases
por: Hao Yu, et al.
Publicado: (2017) -
Lasso-grafting of macrocyclic peptide pharmacophores yields multi-functional proteins
por: Emiko Mihara, et al.
Publicado: (2021) -
Design, synthesis and applications of responsive macrocycles
por: Jingjing Yu, et al.
Publicado: (2020)